نتائج البحث - Martina Dameri

  • يعرض 1 - 5 نتائج من 5
تنقيح النتائج
قائمة   شبكة  
  1. 1

    Comprehensive analysis of plasma methylome reveals distinct patterns of methylation changes between responders and non-responders to neoadjuvant chemotherapy in breast cancer حسب Francesco Ravera, Martina Dameri, Pier Vitale Nuzzo, Mario Stabile, Piero Fregatti, Alberto Ballestrero, Lorenzo Ferrando, Gabriele Zoppoli

    منشور في 2024-12-01
    احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  2. 2

    Development of a hoRizontal data intEgration classifier for NOn-invasive early diAgnosis of breasT cancEr: the RENOVATE study protocol حسب Gabriele Zoppoli, Alberto Ballestrero, Valerio Gaetano Vellone, Piero Fregatti, Francesco Ravera, Gabriella Cirmena, Martina Dameri, Maurizio Gallo, Daniele Friedman, Massimo Calabrese, Alberto Tagliafico, Lorenzo Ferrando

    منشور في 2021-12-01
    احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  3. 3

    Liquid biopsy in breast cancer: Redefining precision medicine حسب Maria Luisa Schiavone, Rosa Scarpitta, Francesco Ravera, Sara Bleve, Carolina Reduzzi, Federico Di Cocco, Martina Dameri, Gabriele Zoppoli, Antonio Giuseppe Naccarato, Pier Vitale Nuzzo, Massimo Cristofanilli, Giuseppe Nicolò Fanelli, Cristian Scatena

    منشور في 2025-09-01
    احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  4. 4

    Incidence and immunomic features of apyretic COVID-19 in patients affected by solid tumors: a prospective cohort study حسب Francesco Ravera, Roberto Borea, Gabriella Cirmena, Martina Dameri, Lorenzo Ferrando, Maurizio Gallo, Cecilia Casini, Neri Fallani, Mario Stabile, Valentina Barbero, Roberto Murialdo, Lucia Tixi, Margherita Cappuccio, Andrea Cuboni, Irene Sivieri, Giuseppe Fornarini, Andrea De Maria, Alberto Ballestrero, Gabriele Zoppoli

    منشور في 2022-05-01
    احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  5. 5

    ESR1 gene amplification and MAP3K mutations are selected during adjuvant endocrine therapies in relapsing Hormone Receptor-positive, HER2-negative breast cancer (HR+ HER2- BC). حسب Lorenzo Ferrando, Andrea Vingiani, Anna Garuti, Claudio Vernieri, Antonino Belfiore, Luca Agnelli, Gianpaolo Dagrada, Diana Ivanoiu, Giuseppina Bonizzi, Elisabetta Munzone, Luana Lippolis, Martina Dameri, Francesco Ravera, Francesco Ravera, Marco Colleoni, Giuseppe Viale, Luca Magnani, Alberto Ballestrero, Gabriele Zoppoli, Giancarlo Pruneri

    منشور في 2023-01-01
    احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:

أدوات البحث: